Synapse - Susan Slovin

Results (254)

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality

Meeting Abstract

Keegan, N. M.; Vasselman, S. E.; Barnett, E.; Nweji, B.; Carbone, E.; Blum, A.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors

Journal Article

Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

TROP-2 co-expression with androgen receptor splice variants as a new therapeutic target in prostate cancer

Meeting Abstract

Stahlfeld, C.; Sperger, J.; Slovin, S. F.; Tagawa, S. T.; Kyriakopoulos, C.; Kohli, M.; Wang, L. G.; Wang, L. W.; Dehm, S.; Lang, J. M.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Interim results of AASUR: A single arm, multi-center phase 2 trial of apalutamide (A) + abiraterone acetate + prednisone (AA plus P) + leuprolide with stereotactic ultra-hypofractionated radiation (UHRT) in very high risk (VHR), node negative (N0) prostate cancer (PCa)

Meeting Abstract

McBride, S. M.; Spratt, D. E.; Kollmeier, M.; Abida, W.; Xiao, H.; Slovin, S. F.; Paller, C. J.; Deville, C.; Den, R. B.; Hearn, J. W. D.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Randomized phase 2 trial of abiraterone acetate plus prednisone, degarelix, or the combination in men with biochemically recurrent prostate cancer after radical prostatectomy

Journal Article

Autio, K. A.; Antonarakis, E. S.; Mayer, T. M.; Shevrin, D. H.; Stein, M. N.; Vaishampayan, U. N.; Morris, M. J.; Slovin, S. F.; Heath, E. I.; Tagawa, S. T.; more...
European Urology Open Science (2021)

Fulltext@MSK | Save

Cardiovascular safety of degarelix versus leuprolide in patients with prostate cancer: The primary results of the PRONOUNCE randomized trial

Journal Article

Lopes, R. D.; Higano, C. S.; Slovin, S. F.; Nelson, A. J.; Bigelow, R.; Sørensen, P. S.; Melloni, C.; Goodman, S. G.; Evans, C. P.; Nilsson, J.; more...
Circulation (2021)

Fulltext@MSK | Save

Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing

Journal Article

Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
Molecular Therapy - Methods & Clinical Development (2021)

Fulltext@MSK | Save

RNA based approaches to profile oncogenic pathways from low quantity samples to drive precision oncology strategies

Journal Article

van de Stolpe, A.; Verhaegh, W.; Blay, J. Y.; Ma, C. X.; Pauwels, P.; Pegram, M.; Prenen, H.; De Ruysscher, D.; Saba, N. F.; Slovin, S. F.; more...
Frontiers in Genetics (2021)

Fulltext@MSK | Save

Immunomodulatory activity of a colony-stimulating factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: A phase I study

Journal Article

Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S. W.; Slovin, S. F.; Adamow, M.; Blinder, V. S.; Brahmachary, M.; Carlsen, M.; Comen, E.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC)

Meeting Abstract

Vargas Pivato de Almeida, D.; Anderson, J.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Dayan, E. S.; Curley, T.; Arauz, G.; Baser, R. E.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save